Literature DB >> 1591371

Changes in the coagulation-fibrinolysis balance of endothelial cells and mononuclear phagocytes: role in disseminated intravascular coagulation associated with infectious diseases.

N Semeraro1, M Colucci.   

Abstract

Over the last few years, evidence has accumulated that the pathogenetic mechanism of disseminated intravascular coagulation encountered in patients with infectious diseases is extraordinarily complex and involves multiple interactions between the microorganism itself and/or a number of mediators, both microorganism derived and host manufactured, and multifunctional cellular systems, namely endothelial cells and mononuclear phagocytes. In particular, infectious agents and mediators shift the coagulation-fibrinolysis equilibrium of these cells towards fibrin formation and accumulation, via enhancement of procoagulant properties and reduction of both anticoagulant and fibrinolytic capacities. New insights into the pathogenetic mechanism may have important implications for the management of infected patients with disseminated intravascular coagulation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1591371      PMCID: PMC7102176          DOI: 10.1007/bf02591649

Source DB:  PubMed          Journal:  Int J Clin Lab Res        ISSN: 0940-5437


  56 in total

Review 1.  Activation of the immune coagulation system by murine hepatitis virus strain 3.

Authors:  G Levy; M Abecassis
Journal:  Rev Infect Dis       Date:  1989 May-Jun

2.  Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome.

Authors:  S Idell; K K James; E G Levin; B S Schwartz; N Manchanda; R J Maunder; T R Martin; J McLarty; D S Fair
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

3.  Detection of both type 1 and type 2 plasminogen activator inhibitors in human monocytes.

Authors:  J C Castellote; E Grau; M A Linde; N Pujol-Moix; M L Rutllant
Journal:  Thromb Haemost       Date:  1990-02-19       Impact factor: 5.249

4.  Coordinate expression of macrophage procoagulant and fibrinolytic activity in vitro and in vivo.

Authors:  H A Chapman; Z Vavrin; J B Hibbs
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

5.  Clinical trials with human tumor necrosis factor: in vivo and in vitro effects on human mononuclear phagocyte function.

Authors:  P R Conkling; C C Chua; P Nadler; C S Greenberg; E Doty; M A Misukonis; A F Haney; R C Bast; J B Weinberg
Journal:  Cancer Res       Date:  1988-10-01       Impact factor: 12.701

6.  Human recombinant interleukin-1 beta- and tumor necrosis factor alpha-mediated suppression of heparin-like compounds on cultured porcine aortic endothelial cells.

Authors:  M Kobayashi; K Shimada; T Ozawa
Journal:  J Cell Physiol       Date:  1990-09       Impact factor: 6.384

7.  Types 1 and 2 plasminogen activator inhibitor and tumor necrosis factor alpha in patients with sepsis.

Authors:  J A Páramo; J L Pérez; M Serrano; E Rocha
Journal:  Thromb Haemost       Date:  1990-08-13       Impact factor: 5.249

8.  Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha.

Authors:  M Sawdey; T J Podor; D J Loskutoff
Journal:  J Biol Chem       Date:  1989-06-25       Impact factor: 5.157

9.  Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.

Authors:  M P Bevilacqua; J S Pober; G R Majeau; W Fiers; R S Cotran; M A Gimbrone
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

10.  Cultured human endothelial cells generate tissue factor in response to endotoxin.

Authors:  M Colucci; G Balconi; R Lorenzet; A Pietra; D Locati; M B Donati; N Semeraro
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

View more
  3 in total

1.  Sepsis-associated disseminated intravascular coagulation and thromboembolic disease.

Authors:  Nicola Semeraro; Concetta T Ammollo; Fabrizio Semeraro; Mario Colucci
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-08-13       Impact factor: 2.576

2.  Disseminated intravascular coagulation associated with disseminated cryptococcosis in a patient with acquired immunodeficiency syndrome.

Authors:  G Fera; N Semeraro; V De Mitrio; O Schiraldi
Journal:  Infection       Date:  1993 May-Jun       Impact factor: 3.553

3.  Indoor nanoscale particulate matter-induced coagulation abnormality based on a human 3D microvascular model on a microfluidic chip.

Authors:  Yan Li; Chuanlin Hu; Pengcheng Wang; Yan Liu; Luyang Wang; Qingmeng Pi; Zhiyong Gong; Xu Yang; Michael Mak; Yang Wu
Journal:  J Nanobiotechnology       Date:  2019-02-01       Impact factor: 10.435

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.